Physical Activity Guarantees Bone Density.
NCT06606769
Behavior, Bone Diseases
Poznan, Poland
View Trial DetailsNCT Number: NCT07812402
This is a single-center prospective cross-sectional study with a follow-up period of 6 months. All patients met the inclusion criteria and requested DXA at the outpatient clinics of Ankara Etlik City Hospital Physical Therapy and Rehabilitation Hospital. Sample size was performed using the statistical power analysis program for G*Power 3.1.9.6 Mac. Based on the study by Tuna et al. aiming to evaluate the rate of poor positioning of patients during DXA and the accuracy of the analysis, the minimum required number of patients (with a 95% working power and 95% confidence interval with a 5% Type 1 and 20% Type 2 margin of error and a 95% working power and 95% confidence interval) was found to be 530. It was decided to include at least 530 patients in the study.
This study is active but is not currently recruiting participants.
Notify Me18 year and older
All sexes
Observational
Ankara Etlik City Hospital, Ankara, Turkey (Türkiye)
Osteoporosis is a progressive disease characterized by low bone mass and deterioration of bone microarchitecture.
With aging, a decrease in bone strength and an increased risk of fractures occur. Osteoporosis is considered a silent disease, as it usually presents no symptoms until the first fracture occurs.
The World Health Organization defines osteoporosis using a T-score derived from dual-energy X-ray absorptiometry (DXA) measurements of bone mineral density (BMD) in the hip and spine. The T-score represents a standard deviation that indicates how much a result differs from the average or mean bone mineral density. DXA measurements of hip and spinal BMD are crucial clinical tools for assessing and screening individuals at risk for osteoporosis.
Dual-energy X-ray absorptiometry is the most appropriate and accessible method used to diagnose osteoporosis, assess the risk of fractures in patients, and ensure effective follow-up. However, numerous studies have pointed out the limitations of this imaging method, demonstrating that factors such as osteoarthritis, surgical implants, scoliosis, and lumbar vertebral positioning can lead to misleading results. Furthermore, previous research has reported that one of the most significant sources of error is improper patient positioning during the scan.
Although DXA provides high accuracy in measuring bone mineral density, its sensitivity depends on operators, equipment, and various patient-related factors. There are numerous devices in use for DXA scanning in our country. However, the training of radiology technicians performing these scans has not yet been standardized. Some studies have reported that the rate of erroneous DXA scans is considerably high. Therefore, information regarding the impact of these erroneous scans on the diagnosis and treatment of osteoporosis remains limited. The aim of this study is to identify errors in DXA scans performed in our center and to determine how these errors affect the diagnosis and treatment decisions for osteoporosis.
Estimated study duration: 6 months
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Time frame: for 1 years
After the scan, DXA results will be reviewed on-site, and errors in lumbar and femoral measurements will be identified separately based on the standards defined in the official measurement guide by the International Society for Clinical Densitometry. Interventions will be made during the scanning process to correct errors, and corrected reports will be generated. DXA results of erroneous and corrected scans for lumbar spine and proximal femur will be compared to assess their impact on the diagnosis and treatment of osteoporosis.
Ankara Etlik City Hospital
Other Gov
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06606769
Behavior, Bone Diseases
Poznan, Poland
View Trial DetailsNCT07739628
Bone Diseases, Bone Diseases, Metabolic
Wuhan, Hubei, China
View Trial DetailsNCT04947722
Bone Diseases, Bone Diseases, Metabolic
Hamilton, Ontario, Canada
View Trial DetailsNCT02194660
Behavior, Bone Diseases
Taipei, Taiwan
View Trial Details